CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 46 filers reported holding CIDARA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,625 | -36.2% | 13,400 | -23.4% | 0.00% | – |
| Q2 2023 | $19,775 | -63.3% | 17,500 | -58.7% | 0.00% | – |
| Q1 2023 | $53,848 | -79.4% | 42,400 | -87.7% | 0.00% | – |
| Q4 2022 | $261,008 | +1907.8% | 345,112 | +1625.6% | 0.00% | – |
| Q3 2022 | $13,000 | -53.6% | 20,000 | -65.1% | 0.00% | – |
| Q2 2022 | $28,000 | +47.4% | 57,350 | +151.5% | 0.00% | – |
| Q1 2022 | $19,000 | -89.3% | 22,800 | -83.7% | 0.00% | – |
| Q4 2021 | $178,000 | +114.5% | 139,785 | +277.4% | 0.00% | – |
| Q3 2021 | $83,000 | +219.2% | 37,041 | +187.9% | 0.00% | – |
| Q2 2021 | $26,000 | -54.4% | 12,865 | -39.7% | 0.00% | – |
| Q1 2021 | $57,000 | +119.2% | 21,336 | +104.5% | 0.00% | – |
| Q1 2020 | $26,000 | -64.9% | 10,433 | -46.2% | 0.00% | – |
| Q4 2019 | $74,000 | +25.4% | 19,396 | +32.6% | 0.00% | – |
| Q1 2018 | $59,000 | -54.3% | 14,631 | -14.6% | 0.00% | – |
| Q2 2017 | $129,000 | -58.4% | 17,137 | -29.7% | 0.00% | – |
| Q3 2015 | $310,000 | -4.6% | 24,391 | +5.1% | 0.00% | – |
| Q2 2015 | $325,000 | – | 23,207 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,627,670 | $1,533,591 | 1.88% |
| 5AM Venture Management, LLC | 1,134,511 | $1,068,936 | 0.31% |
| Nantahala Capital Management | 2,538,406 | $2,391,686 | 0.20% |
| BVF INC/IL | 6,861,127 | $6,464,554 | 0.17% |
| Monashee Investment Management LLC | 369,099 | $347,765 | 0.14% |
| West Family Investments, Inc. | 368,910 | $347,587 | 0.12% |
| JEPPSON WEALTH MANAGEMENT, LLC | 137,560 | $129,609 | 0.06% |
| XTX Topco Ltd | 202,758 | $191,039 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 136,974 | $129 | 0.01% |
| Callan Capital, LLC | 103,462 | $97,482 | 0.01% |